HCA
Harbor Capital Advisors Portfolio holdings
AUM
$2.38B
This Quarter Return
-13.74%
1 Year Return
+20%
3 Year Return
+97.89%
5 Year Return
–
10 Year Return
–
AUM
$212M
AUM Growth
+$212M
(-23%)
Cap. Flow
-$20.9M
Cap. Flow
% of AUM
-9.85%
Top 10 Holdings %
Top 10 Hldgs %
31.86%
Holding
168
New
76
Increased
18
Reduced
66
Closed
8
Top Buys
| 1 |
Amazon
AMZN
|
$3.31M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
$2.8M |
| 3 |
Netflix
NFLX
|
$2.2M |
| 4 |
XYZ
Block, Inc.
XYZ
|
$1.95M |
| 5 |
Meta Platforms (Facebook)
META
|
$1.65M |
Top Sells
| 1 |
Amphenol
APH
|
$7.1M |
| 2 |
NVIDIA
NVDA
|
$5.77M |
| 3 |
Tesla
TSLA
|
$5.59M |
| 4 |
Trex
TREX
|
$2.99M |
| 5 |
RDFN
Redfin
RDFN
|
$2.92M |
Sector Composition
| 1 | Technology | 47.27% |
| 2 | Consumer Discretionary | 18.31% |
| 3 | Healthcare | 16.1% |
| 4 | Communication Services | 12.45% |
| 5 | Financials | 2.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMED
51
DELISTED
Amedisys
AMED
| $1.28M | 0.6% |
7,441
-1,091
| -13% | -$188K |
|
|
BCYC
52
Bicycle Therapeutics
BCYC
$511M
| $1.27M | 0.6% |
28,942
-5,658
| -16% | -$248K |
|
53
Tandem Diabetes Care
TNDM
$845M
| $1.25M | 0.59% |
10,729
-1,565
| -13% | -$182K |
|
54
Rocket Pharmaceuticals
RCKT
$354M
| $1.19M | 0.56% |
75,177
-13,208
| -15% | -$209K |
|
|
CTLT
55
DELISTED
CATALENT, INC.
CTLT
| $1.18M | 0.56% |
10,668
-1,854
| -15% | -$206K |
|
56
Idexx Laboratories
IDXX
$51.8B
| $1.18M | 0.56% |
2,157
+399
| +23% | +$218K |
|
57
Arvinas
ARVN
$568M
| $1.11M | 0.52% |
16,489
-3,144
| -16% | -$212K |
|
58
Regenxbio
RGNX
$451M
| $1.08M | 0.51% |
32,460
-5,793
| -15% | -$192K |
|
59
Cooper Companies
COO
$13.4B
| $1.05M | 0.49% |
2,504
-365
| -13% | -$152K |
|
60
Krystal Biotech
KRYS
$4.27B
| $1.02M | 0.48% |
15,305
-3,167
| -17% | -$211K |
|
61
HubSpot
HUBS
$25.5B
| $1.01M | 0.48% |
+2,131
| New | +$1.01M |
|
|
AVLR
62
DELISTED
Avalara, Inc.
AVLR
| $1M | 0.47% |
10,054
+3,107
| +45% | +$309K |
|
63
Arrowhead Research
ARWR
$3.05B
| $947K | 0.45% |
20,602
-4,756
| -19% | -$219K |
|
64
Thermo Fisher Scientific
TMO
$186B
| $890K | 0.42% |
+1,507
| New | +$890K |
|
65
Bio-Rad Laboratories Class A
BIO
$8.06B
| $878K | 0.41% |
1,559
+49
| +3% | +$27.6K |
|
66
Synlogic
SYBX
$17M
| $852K | 0.4% |
354,998
-82,552
| -19% | -$198K |
|
67
Allogene Therapeutics
ALLO
$251M
| $845K | 0.4% |
92,755
-26,792
| -22% | -$244K |
|
68
Avidity Biosciences
RNA
$5.99B
| $839K | 0.4% |
45,439
-11,209
| -20% | -$207K |
|
|
BPMC
69
DELISTED
Blueprint Medicines
BPMC
| $798K | 0.38% |
12,488
-1,826
| -13% | -$117K |
|
70
Mettler-Toledo International
MTD
$26.8B
| $780K | 0.37% |
+568
| New | +$780K |
|
71
Iovance Biotherapeutics
IOVA
$807M
| $702K | 0.33% |
42,183
-9,357
| -18% | -$156K |
|
|
AUTL
72
Autolus Therapeutics
AUTL
$399M
| $680K | 0.32% |
163,143
-48,176
| -23% | -$201K |
|
73
NextEra Energy, Inc.
NEE
$148B
| $637K | 0.3% |
7,518
-1,101
| -13% | -$93.3K |
|
74
Kymera Therapeutics
KYMR
$2.95B
| $592K | 0.28% |
13,995
-2,856
| -17% | -$121K |
|
75
C4 Therapeutics
CCCC
$185M
| $531K | 0.25% |
21,868
-5,923
| -21% | -$144K |
|